This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Biocis Pharma Oy, Orion Corporation, Delsitech Oy. Active years: 2011-2019.
Company Filing History:
4 out of 4 
2 out of 189 
1 out of 11 Years Active: 2011-2019
Title: Lasse Leino: Innovator in Pharmaceutical Formulations
Introduction
Lasse Leino is a notable inventor based in Merimasku, Finland. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 7 patents. His work focuses on innovative solutions for chronic viral infections and immunosuppression.
Latest Patents
One of Lasse Leino's latest patents is a hydrogel composite depot formulation. This invention involves a biodegradable silica hydrogel composite that incorporates a nucleotide or nucleoside analog reverse transcriptase inhibitor. The formulation is designed to be non-flowing and structurally stable when stored at rest, while also being shear-thinning when subjected to shear stress during injection. This depot formulation is intended for the treatment of chronic viral infections and the prevention of chronic viral reinfection. Additionally, it includes prefilled syringes containing the depot formulation.
Another significant patent is for a pharmaceutical composition aimed at intracellular acidification using cis-urocanic acid. This composition is designed to acidify the cell cytoplasm, which can be useful for causing immunosuppression in individuals or animals. The agent is administered in a non-dissociated form, and the pH of the composition is adjusted to a range of 6.1 to 7.0.
Career Highlights
Lasse Leino has worked with several companies throughout his career, including Biocis Pharma Oy and Orion Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Lasse has collaborated with notable colleagues such as Jarmo Laihia and Mirja Huhtinen. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Lasse Leino is a prominent inventor whose work in pharmaceutical formulations has the potential to significantly impact the treatment of chronic viral infections and immunosuppression. His innovative patents reflect his dedication to advancing medical science.